WuXi Biologics (Cayman) Inc
HKEX:2269
Wall Street
Price Targets
Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for
WuXi Biologics (Cayman) Inc
is 44.44 HKD
with a low forecast of 30.3 HKD and a high forecast of 56.94 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is WuXi Biologics (Cayman) Inc's stock price target?
Price Target
44.44
HKD
According to Wall Street analysts, the average 1-year price target for
WuXi Biologics (Cayman) Inc
is 44.44 HKD
with a low forecast of 30.3 HKD and a high forecast of 56.94 HKD.
What is WuXi Biologics (Cayman) Inc's Revenue forecast?
Projected CAGR
17%
For the last 9 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's revenue is
48%.
The projected
CAGR
for the next 4 years is
17%.
What is WuXi Biologics (Cayman) Inc's Operating Income forecast?
Projected CAGR
22%
For the last 9 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's operating income is
62%.
The projected
CAGR
for the next 4 years is
22%.
What is WuXi Biologics (Cayman) Inc's Net Income forecast?
Projected CAGR
24%
For the last 9 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's net income is
62%.
The projected
CAGR
for the next 4 years is
24%.
